Pimobendan Inhibits HBV Transcription and Replication by Suppressing HBV Promoters Activity.
Yuan SY, Yu HB, Yang Z, Qin YP, Ren JH, Cheng ST, Ren F, Law BYK, Wong VKW, Ng JPL, Zhou YJ, He X, Tan M, Zhang ZZ, Chen J.
Yuan SY, et al. Among authors: zhang zz.
Front Pharmacol. 2022 Jun 3;13:837115. doi: 10.3389/fphar.2022.837115. eCollection 2022.
Front Pharmacol. 2022.
PMID: 35721154
Free PMC article.